​

Stryker (SYK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SYK Stock Forecast

Stryker (SYK) stock forecast, based on 50 Wall Street analysts, predicts a 12-month average price target of $417.00, with a high of $448.00 and a low of $390.00. This represents a 13.81% increase from the last price of $366.39.

$250 $290 $330 $370 $410 $450 High: $448 Avg: $417 Low: $390 Last Closed Price: $366.39

SYK Stock Rating

Stryker stock's rating consensus is Buy, based on 50 Wall Street analysts. The breakdown includes 1 Strong Buy (2.00%), 35 Buy (70.00%), 14 Hold (28.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 50 14 35 1 Strong Sell Sell Hold Buy Strong Buy

SYK Price Target Upside V Benchmarks

TypeNameUpside
StockStryker13.81%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks16.44%

Price Target Trends

1M3M12M
# Anlaysts2916
Avg Price Target$404.00$411.44$417.06
Last Closing Price$366.39$366.39$366.39
Upside/Downside10.27%12.30%13.83%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 268138-130
Dec, 2571310-131
Nov, 2571310-131
Oct, 2571310-131
Sep, 257149-131
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 06, 2026Raymond James$418.00$348.7919.84%14.09%
Jan 05, 2026Evercore ISI$390.00$347.6912.17%6.44%
Nov 14, 2025Richard NewitterTruist Financial$400.00$366.389.18%9.17%
Nov 14, 2025Shagun SinghRBC Capital$435.00$365.1419.13%18.73%
Nov 14, 2025Mike MatsonNeedham$448.00$373.4219.97%22.27%
Nov 03, 2025Truist Financial$392.00$359.369.08%6.99%
Oct 31, 2025Evercore ISI$405.00$357.6013.26%10.54%
Oct 15, 2025Truist Financial$407.00$370.889.74%11.08%
Oct 13, 2025UBS$408.00$364.6011.90%11.36%
Oct 07, 2025Evercore ISI$410.00$366.2811.94%11.90%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 06, 2026Raymond JamesOutperformupgrade
Dec 19, 2025CitigroupBuyOutperformupgrade
Dec 11, 2025CitigroupBuyBuyhold
Nov 14, 2025RBC CapitalOutperformOutperformhold
Nov 14, 2025NeedhamBuyBuyhold
Nov 03, 2025BernsteinOutperformOutperformhold
Oct 22, 2025BarclaysOverweightOverweighthold
Oct 13, 2025BTIGBuyBuyhold
Jul 14, 2025BTIGBuyBuyhold
May 22, 2025CitigroupBuyBuyhold

Financial Forecast

EPS Forecast

$5 $9 $13 $17 $21 $25 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$5.29$6.23$8.34$7.86-----
Avg Forecast$9.11$9.18$10.41$12.05$13.49$14.92$16.63$18.36$20.61
High Forecast$9.20$9.30$10.45$12.09$13.62$15.22$17.86$18.71$21.00
Low Forecast$8.97$9.05$10.37$12.02$13.28$14.60$15.65$18.00$20.20
Surprise %-41.93%-32.14%-19.88%-34.77%-----

Revenue Forecast

$15B $19B $23B $27B $31B $35B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$17.11B$18.45B$20.50B$22.59B-----
Avg Forecast$17.06B$18.21B$20.28B$22.52B$24.46B$26.37B$28.62B$31.09B$33.43B
High Forecast$17.18B$18.40B$20.41B$22.64B$24.75B$26.89B$28.69B$31.54B$33.92B
Low Forecast$16.86B$18.02B$20.23B$22.43B$24.17B$25.98B$28.54B$30.61B$32.91B
Surprise %0.29%1.32%1.05%0.32%-----

Net Income Forecast

$2B $3B $4B $6B $7B $9B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$1.99B$2.36B$3.17B$2.99B-----
Avg Forecast$1.98B$2.16B$3.17B$4.63B$5.16B$5.72B$6.43B$7.05B$7.91B
High Forecast$2.38B$2.59B$3.80B$4.64B$5.23B$5.84B$6.85B$7.18B$8.06B
Low Forecast$1.59B$1.73B$2.53B$4.61B$5.10B$5.60B$6.01B$6.91B$7.75B
Surprise %0.47%9.14%--35.32%-----

SYK Forecast FAQ

Is Stryker stock a buy?

Stryker stock has a consensus rating of Buy, based on 50 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 35 Buy, 14 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Stryker is a favorable investment for most analysts.

What is Stryker's price target?

Stryker's price target, set by 50 Wall Street analysts, averages $417 over the next 12 months. The price target range spans from $390 at the low end to $448 at the high end, suggesting a potential 13.81% change from the previous closing price of $366.39.

How does Stryker stock forecast compare to its benchmarks?

Stryker's stock forecast shows a 13.81% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (16.44%).

What is the breakdown of analyst ratings for Stryker over the past three months?

  • January 2026: 26.67% Strong Buy, 43.33% Buy, 26.67% Hold, 0% Sell, 3.33% Strong Sell.
  • December 2025: 22.58% Strong Buy, 41.94% Buy, 32.26% Hold, 0% Sell, 3.23% Strong Sell.
  • November 2025: 22.58% Strong Buy, 41.94% Buy, 32.26% Hold, 0% Sell, 3.23% Strong Sell.

What is Stryker’s EPS forecast?

Stryker's average annual EPS forecast for its fiscal year ending in December 2025 is $13.49, marking a 71.63% increase from the reported $7.86 in 2024. Estimates for the following years are $14.92 in 2026, $16.63 in 2027, $18.36 in 2028, and $20.61 in 2029.

What is Stryker’s revenue forecast?

Stryker's average annual revenue forecast for its fiscal year ending in December 2025 is $24.46B, reflecting a 8.25% increase from the reported $22.6B in 2024. The forecast for 2026 is $26.37B, followed by $28.62B for 2027, $31.09B for 2028, and $33.43B for 2029.

What is Stryker’s net income forecast?

Stryker's net income forecast for the fiscal year ending in December 2025 stands at $5.16B, representing an 72.46% increase from the reported $2.99B in 2024. Projections indicate $5.72B in 2026, $6.43B in 2027, $7.05B in 2028, and $7.91B in 2029.